<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Adult <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) is a highly <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> stem cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> characterized by the clonal expansion of immature myeloid precursors </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> may emerge de novo, following other <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> or after cytotoxic therapy for other disorders </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we investigated the clonal vs. reactive nature of residual maturing BM cells in 59 newly-diagnosed <z:e sem="disease" ids="C0220615" disease_type="Neoplastic Process" abbrv="">adult AML</z:e> and mixed phenotype <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (MPAL) patients as assessed by interphase fluorescence in situ hybridization analysis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>)-associated cytogenetic alterations and/or the pattern of chromosome X inactivation, in females </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, we investigated the potential association between the degree of molecular/genetic involvement of hematopoiesis and coexistence of altered immunophenotypes by flow cytometry </plain></SENT>
<SENT sid="4" pm="."><plain>Our results indicate that residual maturing neutrophils, monocytes and nucleated red cell precursors from the great majority of newly-diagnosed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and MPAL cases show a clonal pattern of involvement of residual maturing hematopoietic cells, in association with a greater number of altered immunophenotypes </plain></SENT>
<SENT sid="5" pm="."><plain>These findings are consistent with the replacement of <z:mpath ids='MPATH_458'>normal</z:mpath>/reactive hematopoiesis by clonal myelopoiesis and/or erythropoiesis in most newly-diagnosed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and MPAL cases, supporting the notion that in most adults presenting with de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, accumulation of blast cells could occur over a pre-existing clonal hematopoiesis.<z:hpo ids='HP_0001909'>Leukemia</z:hpo> accepted article preview online, 12 April 2013; doi:10.1038/leu.2013.109 </plain></SENT>
</text></document>